Native RNasin® Inhibitor is a 50kDa protein that inhibits RNase A family and human placental RNases by noncovalently binding to RNases in a 1:1 ratio. Recombinant RNasin® Inhibitor does not inhibit RNase T1, S1 nuclease, RNase fromAspergillus, RNase H, RNase ONE™ Ribonuclease and enzymes for downstream applications such as GoScript™ Reverse Transcriptase, AMV/M-MLV reverse transcriptases, SP6, T7/T3 RNA polymerase andTaqDNA polymerases.
Features - Benefits
Inhibits Common Eukaryotic RNases:Carries broad-spectrum RNase inhibitory properties.
Compatible:Does not inhibit SP6, T7 or T3 RNA Polymerase; GoScript™, AMV or M-MLV Reverse Transcriptase; orTaqDNA polymerase.
Broad pH Range (pH 5–8):Offers flexibility in downstream assays.
Applications
RT-PCR.
Useful in any applications where eukaryotic RNase contamination is a potential problem.
Protection of mRNA in cDNA synthesis reactions.
In vitro transcription/translation.
Increase yield and activity of polysomes.
Improvement of in vitro virus replication.
Improvement of RNA translation in homologous systems.
Performing RNase-free antibody staining.
Enhancement of RNA yields from Riboprobe® System RNA synthesis reactions.
References
Blackburn, P. and Moore, S. (1982) In:The Enzymes, Vol. XV, Part B.